PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35492074-0	2022	Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.	Morphine	0-8	Janus kinase 3	Homo sapiens	107-111	
35492074-0	2022	Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.	Morphine	0-8	signal transducer and activator of transcription 5A	Homo sapiens	112-117	
35492074-0	2022	Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.	Ketamine	29-37	Janus kinase 3	Homo sapiens	107-111	
35492074-0	2022	Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.	Ketamine	29-37	signal transducer and activator of transcription 5A	Homo sapiens	112-117	
35492074-7	2022	Western blotting was used for detection of JAK3/STAT5 pathway-related proteins after naltrexone treatment in vitro.	Naltrexone	85-95	Janus kinase 3	Homo sapiens	43-47	
35492074-7	2022	Western blotting was used for detection of JAK3/STAT5 pathway-related proteins after naltrexone treatment in vitro.	Naltrexone	85-95	signal transducer and activator of transcription 5A	Homo sapiens	48-53	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	CD4 molecule	Homo sapiens	93-96	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	CD4 molecule	Homo sapiens	110-113	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	CD8a molecule	Homo sapiens	115-118	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	interferon gamma	Homo sapiens	145-154	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	interleukin 2	Homo sapiens	156-160	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	interleukin 17A	Homo sapiens	166-171	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	Janus kinase 3	Homo sapiens	180-184	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Morphine	58-66	signal transducer and activator of transcription 5A	Homo sapiens	185-190	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	CD4 molecule	Homo sapiens	93-96	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	CD4 molecule	Homo sapiens	110-113	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	CD8a molecule	Homo sapiens	115-118	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	interferon gamma	Homo sapiens	145-154	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	interleukin 2	Homo sapiens	156-160	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	interleukin 17A	Homo sapiens	166-171	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	Janus kinase 3	Homo sapiens	180-184	
35492074-10	2022	The in vitro results demonstrated that the combination of morphine and ketamine may decrease CD4+ percentage, CD4+/CD8+ ratio, and the levels of IFN-gamma, IL-2, and IL-17 via the JAK3/STAT5 pathway.	Ketamine	71-79	signal transducer and activator of transcription 5A	Homo sapiens	185-190	
35492074-11	2022	Conclusions: Our finding indicated that morphine-ketamine combination could improve cancer pain and repress immune function via the JAK3/STAT5 pathway in the progression of CC.	Morphine	40-48	Janus kinase 3	Homo sapiens	132-136	
35492074-11	2022	Conclusions: Our finding indicated that morphine-ketamine combination could improve cancer pain and repress immune function via the JAK3/STAT5 pathway in the progression of CC.	Morphine	40-48	signal transducer and activator of transcription 5A	Homo sapiens	137-142	
35492074-11	2022	Conclusions: Our finding indicated that morphine-ketamine combination could improve cancer pain and repress immune function via the JAK3/STAT5 pathway in the progression of CC.	Ketamine	49-57	Janus kinase 3	Homo sapiens	132-136	
35492074-11	2022	Conclusions: Our finding indicated that morphine-ketamine combination could improve cancer pain and repress immune function via the JAK3/STAT5 pathway in the progression of CC.	Ketamine	49-57	signal transducer and activator of transcription 5A	Homo sapiens	137-142